Kathryn Huber-Keener
Overview
Explore the profile of Kathryn Huber-Keener including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mei S, Chelmow D, Gecsi K, Barkley J, Barrows E, Brooks R, et al.
Obstet Gynecol
. 2023 Jun;
142(1):196-210.
PMID: 37348095
Health disparity, defined by the Centers for Disease Control and Prevention (CDC) as "preventable differences in the burden of disease, injury, violence, or opportunities to achieve optimal health that are...
2.
Burke W, Barkley J, Barrows E, Brooks R, Gecsi K, Huber-Keener K, et al.
Obstet Gynecol
. 2023 Jun;
142(1):179-195.
PMID: 37348094
The Centers for Disease Control and Prevention awarded funding to the American College of Obstetricians and Gynecologists to develop educational materials for clinicians on gynecologic cancers. The American College of...
3.
Chelmow D, Brooks R, Cavens A, Huber-Keener K, Scott D, Sheth S, et al.
Obstet Gynecol
. 2022 Mar;
139(4):626-643.
PMID: 35272316
The Centers for Disease Control and Prevention recognized the need for educational materials for clinicians on the prevention and early diagnosis of gynecologic cancers. The American College of Obstetricians and...
4.
Whetstone S, Burke W, Sheth S, Brooks R, Cavens A, Huber-Keener K, et al.
Obstet Gynecol
. 2022 Mar;
139(4):645-659.
PMID: 35272301
The Centers for Disease Control and Prevention recognized the need for educational materials for clinicians on the prevention and early diagnosis of gynecologic cancers. The American College of Obstetricians and...
5.
Kandagatla P, Rizk N, Dokic D, Kochkodan J, Estevez S, Yanik M, et al.
Breast J
. 2019 Sep;
26(3):464-468.
PMID: 31538708
We sought to identify factors associated with disparities in tamoxifen utilization among young patients at high-risk for developing breast cancer. We identified 67 premenopausal, high-risk women age 35-45, without surgical...
6.
Zhang L, Ren X, Cheng Y, Huber-Keener K, Liu X, Zhang Y, et al.
Biochem Pharmacol
. 2013 Jul;
86(6):726-33.
PMID: 23856293
The current study reports a previously unappreciated role of Sirtuin 3 (SIRT3), a mitochondrial protein deacetylase, in altering sensitivity of breast cancer cells to tamoxifen (Tam), a commonly used anti-estrogen...